Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study

BACKGROUND: The great majority of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infections are mild and uncomplicated, but some individuals with initially mild COVID-19 progressively develop more severe symptoms. Furthermore, there is substantial heterogeneity in SARS-CoV-2-sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zicheng, van der Ploeg, Kattria, Chakraborty, Saborni, Arunachalam, Prabhu S, Mori, Diego AM, Jacobson, Karen B, Bonilla, Hector, Parsonnet, Julie, Andrews, Jason R, Holubar, Marisa, Subramanian, Aruna, Khosla, Chaitan, Maldonado, Yvonne, Hedlin, Haley, de la Parte, Lauren, Press, Kathleen, Ty, Maureen, Tan, Gene S, Blish, Catherine, Takahashi, Saki, Rodriguez-Barraquer, Isabel, Greenhouse, Bryan, Butte, Atul J, Singh, Upinder, Pulendran, Bali, Wang, Taia T, Jagannathan, Prasanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Immunology and Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566856/
https://www.ncbi.nlm.nih.gov/pubmed/36239699
http://dx.doi.org/10.7554/eLife.77943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566856/
https://www.ncbi.nlm.nih.gov/pubmed/36239699
http://dx.doi.org/10.7554/eLife.77943

Ejemplares similares